Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$84.19
-1.49-1.74%
At close: Dec 16, 4:00 PM EST
$84.19
N/A
After Hours: 4:02 PM EST
Comments
Loading...
Kymera Therapeutics (KYMR) Stock Price, Quote, News & History
KYMRNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Kymera Therapeutics (KYMR) stock?
You can purchase shares of Kymera Therapeutics (NASDAQ:KYMR) through any online brokerage.
Who are Kymera Therapeutics (KYMR) competitors?
Other companies in Kymera Therapeutics’s space includes: Immunovant Inc (NASDAQ:IMVT), Cogent Biosciences Inc (NASDAQ:COGT), Celcuity Inc (NASDAQ:CELC), Alkermes PLC (NASDAQ:ALKS) and Vaxcyte Inc (NASDAQ:PCVX).
What is the forecast, or price target, for Kymera Therapeutics (KYMR) stock?
Kymera Therapeutics has a consensus price target of $88.81.
What is the current price for Kymera Therapeutics (KYMR)?
The stock price for Kymera Therapeutics (NASDAQ: KYMR) is $84.19 last updated December 16, 2025 at 4:02 PM EST.
Does Kymera Therapeutics (KYMR) pay a dividend?
There are no upcoming dividends for Kymera Therapeutics.
When is Kymera Therapeutics (NASDAQ:KYMR) reporting earnings?
Kymera Therapeutics does not have any upcoming earnings scheduled.
Is Kymera Therapeutics (KYMR) going to split?
There is no upcoming split for Kymera Therapeutics.
What sector and industry does Kymera Therapeutics (KYMR) operate in?
Kymera Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
